Evidence map›Paper›PMID 36010315›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Integrating Health Data-Driven Machine Learning Algorithms to Evaluate Risk Factors of Early Stage Hypertension at Different Levels of HDL and LDL Cholesterol.

Pen-Chih Liao, Ming-Shu Chen, Mao-Jhen Jhou, Tsan-Chi Chen, Chih-Te Yang, Chi-Jie Lu

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in microbiology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Pen-Chih LiaoDivision of Cardiology, Cardiovascular Center, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.
Ming-Shu ChenDepartment of Healthcare Administration, College of Healthcare and Management, Asia Eastern University of Science and Technology, New Taipei City 220, Taiwan.ORCID 0000-0002-2713-3546
Mao-Jhen JhouGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242, Taiwan.
Tsan-Chi ChenDepartment of Medical Research, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.ORCID 0000-0001-5221-9707
Chih-Te YangDepartment of Business Administration, Tamkang University, New Taipei City 251, Taiwan.ORCID 0000-0001-7234-3107
Chi-Jie LuGraduate Institute of Business Administration, Fu Jen Catholic University, New Taipei City 242, Taiwan.ORCID 0000-0002-7911-2253
Far Eastern Memorial Hospital · TWFu Jen Catholic University · TWAsia University · TWTamkang University · TW

Funding

Far Eastern Memorial Hospital NSC-RD-110-1-10-503& NSC-RD-110-1-10-510Ministry of Science and Technology MOST-110-2221-E-030-010 & MOST-110-2622-H-161-001
6 · The paper itself

Abstract

purposeCardiovascular disease (CVD) is a major worldwide health burden. As the risk factors of CVD, hypertension, and hyperlipidemia are most mentioned. Early stage hypertension in the population with dyslipidemia is an important public health hazard. This study was the application of data-driven machine learning (ML), demonstrating complex relationships between risk factors and outcomes and promising predictive performance with vast amounts of medical data, aimed to investigate the association between dyslipidemia and the incidence of early stage hypertension in a large cohort with normal blood pressure at baseline.

methodsThis study analyzed annual health screening data for 71,108 people from 2005 to 2017, including data for 27 risk-related indicators, sourced from the MJ Group, a major health screening center in Taiwan. We used five machine learning (ML) methods-stochastic gradient boosting (SGB), multivariate adaptive regression splines (MARS), least absolute shrinkage and selection operator regression (Lasso), ridge regression (Ridge), and gradient boosting with categorical features support (CatBoost)-to develop a multi-stage ML algorithm-based prediction scheme and then evaluate important risk factors at the early stage of hypertension, especially for groups with high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels within or out of the reference range.

resultsAge, body mass index, waist circumference, waist-to-hip ratio, fasting plasma glucose, and C-reactive protein (CRP) were associated with hypertension. The hemoglobin level was also a positive contributor to blood pressure elevation and it appeared among the top three important risk factors in all LDL-C/HDL-C groups; therefore, these variables may be important in affecting blood pressure in the early stage of hypertension. A residual contribution to blood pressure elevation was found in groups with increased LDL-C. This suggests that LDL-C levels are associated with CPR levels, and that the LDL-C level may be an important factor for predicting the development of hypertension.

conclusionThe five prediction models provided similar classifications of risk factors. The results of this study show that an increase in LDL-C is more important than the start of a drop in HDL-C in health screening of sub-healthy adults. The findings of this study should be of value to health awareness raising about hypertension and further discussion and follow-up research.

Indexed as

health data-drivenhigh-density lipoprotein cholesterol (HDL-C)hypertensionlow-density lipoprotein cholesterol (LDL-C)machine learning

Identifiers

PMID36010315
PMCPMC9407063
OpenAlexW4291366997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.